Pancontinental Energy NL (ASX:PCL)

Australia flag Australia · Delayed Price · Currency is AUD
0.0110
0.00 (0.00%)
Aug 1, 2025, 3:42 PM AEST

Verve Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2016 - 2020
941799743125
Upgrade
Market Cap Growth
12.10%85.09%125.16%257.31%122.20%-50.00%
Upgrade
Enterprise Value
891739441113
Upgrade
Last Close Price
0.010.020.010.010.000.00
Upgrade
PB Ratio
11.9321.6211.1514.594.481.86
Upgrade
P/TBV Ratio
10.0418.359.539.652.871.23
Upgrade
Debt / Equity Ratio
--0.060.160.180.16
Upgrade
Quick Ratio
4.195.4321.321.742.706.10
Upgrade
Current Ratio
4.195.4321.321.742.706.10
Upgrade
Return on Equity (ROE)
-26.36%-27.60%-32.22%-29.29%-28.21%-86.84%
Upgrade
Return on Assets (ROA)
-7.73%-7.31%-6.87%-13.14%-12.41%-46.91%
Upgrade
Return on Capital (ROIC)
-8.29%-7.79%-7.16%-14.22%-13.25%-48.79%
Upgrade
Earnings Yield
-2.25%-1.31%-1.97%-1.91%-6.56%-63.73%
Upgrade
FCF Yield
-2.09%-1.01%-1.61%-2.57%-6.75%-23.83%
Upgrade
Buyback Yield / Dilution
-2.03%-6.38%-8.50%-24.55%-3.83%-0.59%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.